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Abstract Positioning of the mRNA codon towards the 18S
ribosomal RNA in the A site of human 80S ribosomes has
been studied applying short mRNA analogs containing either
the stop codon UAA or the sense codon UCA with a per£uoro-
aryl azide group at the uridine residue. Bound to the ribosomal
A site, a modi¢ed codon crosslinks exclusively to the 40S sub-
units under mild UV irradiation. This result is inconsistent with
the hypothesis [Ivanov et al. (2001) RNA 7, 1683^1692] which
requires direct contact between the large rRNA and the stop
codon of the mRNA as recognition step at translation termina-
tion. Both sense and stop codons crosslink to the same A1823/
A1824 invariant dinucleotide in helix 44 of 18S rRNA. The data
point to the resemblance between the ternary complexes formed
at elongation (sense codonWaminoacyl-tRNAWAA dinucleotide of
18S rRNA) and termination (stop codonWeRF1WAA dinucleotide
of 18S rRNA) steps of protein synthesis and support the view
that eRF1 may be considered as a functional mimic of amino-
acyl-tRNA.
: 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Understanding eukaryotic translation termination is less
advanced than other steps of protein synthesis (reviewed in
[1^5]). The ribosomal complexes modeling various states of
the ribosomes during the termination have so far not been
crystallized. For better understanding a termination mecha-
nism, one has to know whether any di¡erences can be re-
vealed in the arrangements of sense versus stop codons of
mRNAs at the ribosomal A site towards the ribosomal com-
ponents. To date, even for the better studied bacterial ribo-
somes, there is no de¢nite answer to this question. The
4-thiouridine residue in the ¢rst position of the UAA stop
codon in the A site of bacterial ribosomes crosslinks to the
C1407 residue of the 16S rRNA [6]. Crosslinking in the 1385^
1420 region of 16S rRNA containing C1407 was found for all
s4UGAN and s4UAAN stop signals [7]. With the s4U residue
in the ¢rst position of the A site-bound sense codon, the
crosslinked nucleotide was identi¢ed in the rRNA as the
C1402/C1407 site [8]. Recent X-ray crystallographic data on
the location of the mRNA and tRNAs within the bacterial
30S ribosomal subunit showed that the ¢rst nucleotide of the
A site-bound sense codon is located close to C1401 of the 16S
rRNA [9].
It was found that class 1 release factors (RFs) (in particular
RF2) promoting hydrolysis of peptidyl-tRNA bound to the
P site contacts the A site-bound stop codon and does not
a¡ect its position with respect to the 16S rRNA (reviewed
in [2]). At present, nothing is known concerning interaction
between stop codons and rRNA in the A site of eukaryotic
ribosomes. For these ribosomes, it was shown that eRF1 con-
tacts the A site-bound stop codon [10,11] and the site of eRF1
involved in this contact has been determined [12]. However,
little is known regarding the placement of the A site-bound
stop codon towards the rRNAs and possible e¡ects of eRF1.
The A1491G, U1495C, U912C and G886A replacements in
yeast 18S rRNA compensated the arbitrarily lethal Pro86Ala
mutation in eRF1 [13]. Besides, the protein environment of a
mRNA stop codon bound to the A site of human ribosomes
was studied with the use of short mRNA analogs composed
of sense and nonsense codons and bearing a per£uoroaryl
azide group on the ¢rst nucleotide of the stop codon [11].
In addition to class 1 RFs, another group of proteins called
class 2 RFs (RF3 and eRF3 in prokaryotes and eukaryotes,
respectively) is involved in termination and post-termination
steps of translation. Class 2 RFs are GTPases [14^16] which
activity depends on the class 1 RFs [14,17,18]. Bacterial RF3
is a GTP-GDP exchange factor responsible for the release of
RF1/RF2 from the ribosome after completion of the trans-
lation termination reaction [17,18], while the biological role of
eRF3 remains obscure although possibly its function is similar
to prokaryotic RF3 [1].
Recently, a hypothesis has been proposed that two hairpins
of the rRNA of the large subunit recognize stop codons di-
rectly by their complementary ‘anticodon-like’ loops [19].
Although crosslinking studies revealed no contacts between
mRNA stop codon and the rRNA of the large subunit at
the A site of bacterial ribosomes [6], it seemed reasonable to
test this hypothesis also on mammalian ribosomes.
Here, we have compared positioning of the A site-bound
sense and stop codons toward the large and small subunit
rRNAs and studied the e¡ects of the eRFs on the interaction
0014-5793 / 03 / $22.00 K 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00755-5
*Corresponding author. Fax: (7)-3832-33 36 77.
E-mail address: karpova@niboch.nsc.ru (G.G. Karpova).
FEBS 27477 15-7-03
FEBS 27477 FEBS Letters 548 (2003) 97^102
of the A site-bound stop codon with 18S rRNA. We have
applied derivatives of the UUCUAAA heptaribonucleotide
(containing the UUC codon for Phe and the stop signal
UAAA) and UUCUCAA heptaribonucleotide (with UCA co-
don for Ser instead of the stop codon), that bore a per£uoro-
aryl azide group at the fourth nucleotide.
2. Materials and methods
2.1. Materials
tRNAPhe (1300 pmol/A260 unit) was a kind gift from Dr. T. Shap-
kina (Konstantinov’s St. Petersburg Institute of Nuclear Physics, Gat-
china, Russia). Isolation of the 40S and 60S ribosomal subunits from
unfrozen human placenta and their association into 80S ribosomes
were performed as described [20]. The full-length human eRF1 carry-
ing a His6-tag at the N-terminus was expressed, puri¢ed and assayed
as described [21,22]. Human eRF3 was puri¢ed as described [23].
2.2. Photoreactive mRNA analogs
Synthesis of derivatives of the heptaribonucleotide UUCUAAA or
UUCUCAA that carry the 2-(4-azido-2,3,5,6-tetra£uorobenzoyl)-ami-
noethyl group on the C5 atom of the fourth nucleotide (azido-
mRNAs) was performed as described [24]. The photoactivatable moi-
ety was coupled to the aliphatic amino group by treatment with the
N-oxysuccinimide ester of p-azidotetra£uorobenzoic acid as described
[24]. Before use, azido-mRNAs were 5P-end-labeled with [Q-32P]ATP
(speci¢c activity about 1000 Ci/mmol) by T4 polynucleotide kinase
purchased from Promega.
2.3. Complexes and crosslinking procedures
Preparation of the complexes of 80S ribosomes with tRNAPhe, azi-
do-mRNAs and eRFs, crosslinking and dissociation of the crosslinked
ribosomes into 40S and 60S subunits were performed as described
[11]. Analysis of crosslinking to RNAs, determination of regions of
the 18S rRNA that contained the crosslinked mRNA analogs and of
the crosslinked 18S rRNA nucleotides were carried out as described
[25].
3. Results
The A site location of a modi¢ed UAA stop codon or a
UCA sense codon in the 80S ribosomal complexes with azido-
pUUCUAAA or azido-pUUCUCAA was achieved by
tRNAPhe targeting the cognate UUC codon to the P site. In
these complexes, the modi¢ed uridine was situated in the +4
position of the mRNA with respect to the ¢rst nucleotide of
the P site-bound codon. Without tRNA, binding of the
mRNA analogs was negligible. Mild UV irradiation of the
complexes obtained with tRNAPhe resulted in crosslinking of
the labeled azido-mRNAs exclusively to the 40S subunits ; no
radioactivity was detected in the fractions containing 60S sub-
units (data for azido-pUUCUAAA are presented in Fig. 1).
Analysis of the RNA isolated from the crosslinked com-
plexes by denaturing PAGE (Fig. 2) showed a strong modi¢-
cation of 18S rRNA and a weak crosslinking to tRNA. Be-
sides, crosslinking to partially degraded 18S rRNA fragments
(not detectable in the stained gels) was noticed. Modi¢cation
of tRNA was decreased in the presence of eRF3 together with
eRF1 (Fig. 2, lane 4). Crosslinking to 18S rRNA was almost
completely dependent on the presence of tRNAPhe and was
hardly detectable in binary mixtures of azido-mRNAs with
80S ribosomes (Fig. 2, lanes K1 and K2). Evidently, this
was due to the negligible binding of azido-mRNAs to ribo-
somes without tRNA. eRF1 alone or together with eRF3 did
not a¡ect the crosslinking of azido-mRNAs to 18S rRNA in
the presence of tRNAPhe.
To determine the sequences in the 18S rRNA containing the
crosslinked nucleotides, 18S rRNA isolated from the irradi-
ated complexes was digested with RNase H in the presence of
deoxy-oligomers complementary to various fragments of 18S
rRNA in parallel experiments (see scheme in Fig. 3). The
hydrolytic fragments of the 18S rRNA were separated by
PAGE under denaturing conditions. Part of the rRNA that
contained the crosslinked 32P-labeled mRNA analog was de-
tected by autoradiography (Fig. 3). The analysis revealed that
the crosslinking sites were located within the 1812^1831 frag-
ment of 18S rRNA for all complexes. This conclusion was
based on the absence of 32P label in the lanes corresponding
to the hydrolysis of the crosslinked 18S rRNA in the presence
of deoxy-oligomer complementary to positions 1812^1831
(Fig. 3, lanes 4). The results of RNase H digestion in the
Fig. 1. Crosslinking of [5P-32P]azido-pUUCUAAA to the ribosomal
subunits. The 80S ribosomal complexes were obtained in the pres-
ence of tRNAPhe, irradiated and sedimented in sucrose density gra-
dient (10^30%) under conditions of dissociation of 80S ribosomes
into the 40S and 60S subunits. Solid line, optical density (typical
pro¢le); dotted lines, radioactivity. 1, without eRFs; 2, with eRF1.
Fig. 2. Radioautographic analysis of crosslinking of 5P-32P-labeled
azido-mRNAs to 18S rRNA and tRNA by electrophoresis in 5%
polyacrylamide gels. The RNA isolated from 80S ribosomal com-
plexes of azido-pUUCUCAA (left part) and azido-pUUCUAAA
(right part) with (lanes 1^4) and without (lanes K1 and K2)
tRNAPhe. Lanes 3 and 4 correspond to the complexes obtained in
the presence of eRF1 and or eRF3+eRF1, respectively. The posi-
tions of 18S rRNA and tRNA are marked as they were seen in the
gels stained with ‘Stains All’.
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presence of other deoxy-oligomers (Fig. 3, lanes 2, 3 and 5)
are consistent with this location for the crosslinking site.
Nucleotides of 18S rRNA crosslinked to azido-mRNAs
were identi¢ed by a primer extension approach; the primer
was chosen on the basis of RNase H treatment data. Since the
crosslinking site is generally assumed to be 5P to the primer
extension stop or pause site, crosslinked nucleotides of 18S
rRNA are A1823 and A1824 (Fig. 4) for complexes of both
mRNA analogs formed in the presence of tRNAPhe. For azi-
do-pUUCUAAA, the primer extension pattern was not af-
fected by eRF1 or by a mixture of eRF3 and eRF1. Note
that 18S rRNA isolated directly from placenta tissue and
without crosslinking was used for the sequencing. This is
why several stops seen at the top of lanes 1^4 and K are
absent in the sequencing lanes (Fig. 4).
4. Discussion
Recently, we showed that derivatives of the UUCUAAA
heptaribonucleotide that carry a per£uoroaryl azide group
at the designed positions of the termination tetraplet UAAA
are valuable tools for studying the vicinity of the A site-bound
stop signal on human ribosomes. Binding of these mRNA
analogs to 80S ribosomes is substantial only in the presence
of tRNAPhe that directs the UUC codon to the P site and
targets the modi¢ed stop signal to the A site. Modi¢ed nu-
cleotides of the A site-bound stop signal could be speci¢cally
crosslinked to eRF1 [11].
Here, we found that crosslinking of the modi¢ed uridine at
position +4 of the heptanucleotide to 18S rRNA is indepen-
dent of the codon nature containing the modi¢ed nucleotide
(sense or stop codon) (Fig. 4). Even more, the crosslinking is
insensitive to the presence of eRF1 at the A site. In contrast,
addition of eRF1 to the phased system obtained with a 42-
mer containing the GAC triplet encoding Asp and s4UGA as
stop codon, decreased the yield of crosslinks of the mRNA to
rRNA [10,12]. In the case of the UUCUAAA derivative, a
£exible spacer separating the ¢rst nucleotide of the stop codon
and the photoactivated group, allowed to produce crosslinks
with the rRNA despite the presence of eRF1 in the A site. On
the other hand, eRF1 and eRF3 together (but not eRF1
alone) partially shielded the stop codon from the crosslinking
to the P site-bound tRNAPhe (Fig. 2). It is known that the
C domain of eRF3 binds to the C domain of the A site-bound
human eRF1 [26]. The latter resembles an L-shaped tRNA
molecule in which the C domain mimics the elbow of tRNA
while the conserved anticodon-like NIKS loop is in contact
with the stop codon [12]. Our observation that eRF3 in com-
plex with eRF1 partially protects the P site-bound tRNA from
crosslinking to the modi¢ed stop codon bound in the A site
indicates that at least part of the eRF3 (but not its C domain)
is probably positioned between the NIKS loop of eRF1 and
the P site-bound tRNA.
The invariant dinucleotide A1823/A1824 crosslinked to the
modi¢ed nucleotides of azido-mRNAs is located in the
3P-terminal mini-domain of 18S rRNA in the upper part of
Fig. 3. Ribonuclease H digests of 18S rRNA crosslinked to 5P-labeled azido-mRNAs. Ternary complexes of 80S ribosomes with tRNAPhe and
either azido-pUUCUCAA (panel I) or azido-pUUCUAAA (panel II); 80S ribosomal complexes with azido-pUUCUAAA and tRNAPhe ob-
tained in the presence of eRF1 (panel III), and in the presence of eRF1 together with eRF3 (panel IV). The image is from autoradiograms of
the gels. Lanes ‘1’ are control rRNA treated with ribonuclease H but without deoxy-oligomers. Positions of 18S rRNA and the excised frag-
ments (the expected lengths are marked, lengths of the crosslinked mRNA analogs have been subtracted) are indicated. Scheme of the hydroly-
sis of crosslinked 18S rRNA is given on the left. Fragments of 18S rRNA complementary to the deoxy-oligomers are shaded, fragments con-
taining the crosslinked labeled mRNA analog are black. Numbers 1^5 on the scheme correspond to the lanes 1^5 on panels I^IV.
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helix 44, one of the most highly conserved fragments of the
secondary structure of the small subunit rRNA (Fig. 5), and
corresponds to the A1492/A1493 dinucleotide of 16S rRNA
[27,28]. These nucleotides are known to play a key role in the
formation of the decoding site of bacterial ribosomes [9,29,30]
and in recognition of correct codon^anticodon duplexes on
the A site [31]. Surprisingly, A1492/A1493 of 16S rRNA
have never been found at least to our knowledge in the decod-
ing site of bacterial ribosomes by means of crosslinking of
mRNA analogs containing 4-thiouridine in position +4. Evi-
dently, this was due to hydrogen bonds of the A1492/A1493
nucleotides of 16S rRNA formed with nucleotides of the A
site-bound codon via hydroxyl groups of the 1492 and 1493
riboses [31]. Therefore, 4-thiouridine interacting with these
riboses was unable to contact adenines 1492 and 1493 and
crosslinked to a 1398^1419 sequence of 16S rRNA [8] that
is located directly across from the A1492/A1493 in the upper
part of helix 44 (Fig. 5).
In the present study, a modifying group on uridine in posi-
tion +4 could reach the A1823/A1824 dinucleotide of 18S
rRNA due to a £exible spacer between the uridine residue
and the per£uoroaryl azide group. Our results together with
the data on bacterial ribosomes [7,8] imply that the upper part
of helix 44 of the small subunit rRNA plays an universal role
in the formation of the decoding site of bacterial and mam-
malian ribosomes and interacts with the A site-bound codon
during the elongation and termination steps of translation.
Earlier, several hypotheses concerning the structural basis
of stop codon recognition during termination were proposed
(reviewed in [32]). Initially, bacterial RF2 was assumed to
recognize the A site-bound stop codon directly (see [2]). Alter-
natively, it was suggested for prokaryotes that two fragments
in 16S rRNA (in helices 34 and 44) together with the stop
codon triplet form a unique complex that may be speci¢cally
recognized by RF2 [33]. If an analogous complex is formed
between the A site-bound sense codon and 16S rRNA it
should be distinguished by class 1 RFs. To achieve this dis-
crimination, the spatial structure of the complexes should dif-
fer. However, at least in eukaryotes as shown here, the com-
plexes look identical. In addition, there are no di¡erences in
the protein environment of the A site-bound sense and stop
codons on mammalian ribosomes [11]. This implies that the
speci¢city of stop codon recognition is brought by a class 1
RF, rather than by the ribosomal components. This is entirely
consistent with the earlier conclusion that eRF1 and not the
ribosome governs the stop codon recognition [34].
A hypothesis has been proposed that the A site-bound stop
codon is recognized by the complementary ‘anticodons’ of
two tRNA-like folds of the large subunit rRNA (namely, hair-
pin 69 of domain IV and hairpin 89 from domain V), and that
RFs only assist in this recognition [19]. If interaction between
the stop codon and the above-mentioned hairpins of 28S
rRNA does occur, the conformationally £exible modifying
group on the uridine of the A site-bound stop codon of azi-
do-pUUCUAAA should reach the 28S rRNA. Our results
show that a modi¢ed stop codon on the ribosomal A site is
Fig. 4. Identi¢cation of 18S rRNA crosslinks sites to azido-mRNAs
by reverse transcription. I, azido-pUUCUCAA; II and III, azido-
pUUCUAAA. Extension of 5P-32P-labeled primer (complementary
to 18S rRNA positions 1830^1849) on the 18S rRNA isolated from
the irradiated complexes. Lanes 1 correspond to binary mixtures of
azido-mRNAs with 80S ribosomes; lanes 2, ternary complexes of
80S ribosomes with azido-mRNAs and tRNAPhe ; lanes 3 and 4,
complexes obtained in the presence of eRF1 and eRF1 together
with eRF3, respectively. Lanes K are control 18S rRNA samples
isolated from 80S ribosomes irradiated without mRNAs and treated
in the same way as the other samples. Lanes U, G, C, A are se-
quencing of the 18S rRNA isolated from placenta tissue. Positions
of the reverse transcription stops caused by crosslinking are indi-
cated.
Fig. 5. Secondary structure of the 3P-terminal mini-domain of hu-
man 18S rRNA [27,28]. Nucleotides of Escherichia coli 16S rRNA
corresponding to the marked nucleotides of 18S rRNA by their po-
sitions in the secondary structure are shown in italics and in brack-
ets. Nucleotide C1708 of 18S rRNA corresponds to C1407 that had
been found to be crosslinked to stop codon bound to the A site of
bacterial ribosomes [6].
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unable to crosslink to the large subunit rRNA both in the
presence or absence of eRF1 (Fig. 1). This implies that the
28S rRNA does not interact with the stop codon and, there-
fore, the hypothesis suggested in [19] most probably is not
applicable at least for mammalian ribosomes.
As shown previously [10] and in this study, eRF1 does not
prevent stop codon crosslinking to 18S rRNA, and 18S rRNA
does not block the crosslinking of the stop codon to eRF1. In
other words, the eRF1, the stop codon and the AA dinucleo-
tide of 18S rRNA are positioned close to each other and
potentially are able to form a ternary complex between the
stop codon, eRF1 and the 18S rRNA fragment at the decod-
ing site of the eukaryotic ribosome. This explains why muta-
tions of both rRNA (see [13]) and eRF1 [35,36] cause alter-
ations in stop codon recognition.
At the elongation step of protein synthesis, a ternary com-
plex of prokaryotic ribosome composed of a codon^anticodon
duplex between the mRNA and aminoacyl-tRNA associated
with the conserved nucleotides of the 16S rRNA has been
demonstrated (see [37]). Here, for mammalian ribosomes, we
observed a close similarity between sense and stop codon in-
teractions with the same AA dinucleotide of 18S rRNA. It
was shown earlier that a modi¢ed guanosine residue at the
¢rst position of the A site-bound sense codon crosslinks to
this 18S rRNA dinucleotide in the ribosomal complexes with
a free A site or the A site occupied with aminoacyl-tRNA [24].
The resemblance or even identity of the interactions of the A
site-bound stop and sense codons with their ligands indicates
that the decoding site is not remarkably changed when amino-
acyl-tRNA is substituted by eRF1. Previous data [10,11] and
those presented here support the view [32] that the decoding
site of the eukaryotic ribosome at the termination step of
translation is likely to be composed of ternary complex be-
tween a stop codon, eRF1 and the AA dinucleotide of the 18S
rRNA similarly to a prokaryotic decoding site. Consequently,
eRF1 is in fact a functional mimic of aminoacyl-tRNA as
suggested earlier [38,39].
Recent cryo-EM [40,41] and chemical probing [42] data on
prokaryotic ribosomes charged with RF2 and a stop codon-
containing mRNA are consistent with the view that the GGQ
motif is located at the peptidyl transferase center of the ribo-
some as proposed earlier [43,44]. However, di¡erent nucleo-
tides of a large subunit rRNA are implicated at elongation
and termination steps of translation [45] indicating that tRNA
mimicry seems to be functional rather than structural as dis-
cussed elsewhere [46].
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